42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen.

Saved in:
Bibliographic Details
Title: 42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen.
Authors: Gerritse, S.1 (AUTHOR), ter Heine, R.2 (AUTHOR), Labots, M.3 (AUTHOR), van den Hombergh, E.2 (AUTHOR), Dekker, H.3 (AUTHOR), Lehutová, D.3 (AUTHOR), Rudek, M.4 (AUTHOR), van Erp, N.2 (AUTHOR), Verheul, H.1 (AUTHOR)
Source: European Journal of Cancer. 2020 Supplement 2, Vol. 138, pS19-S19. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/S0959-8049(20)31114-X